Kimelman & Baird, LLC Abbott Laboratories Transaction History
Kimelman & Baird, LLC
- $1.25 Trillion
- Q3 2024
A detailed history of Kimelman & Baird, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Kimelman & Baird, LLC holds 29,939 shares of ABT stock, worth $3.4 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
29,939
Previous 29,939
-0.0%
Holding current value
$3.4 Million
Previous $3.11 Billion
9.72%
% of portfolio
0.27%
Previous 0.26%
Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,186Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.7 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$7.46 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.05 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $199B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...